iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
Elizabeth Holt, with a proven track record of forging successful life sciences partnerships, appointed as Chief Business Officer (CBO) Dr Mark Velleca appointed as Board Chair, bringing considerable experience in company building and drug development Geneva, Switzerland and Amsterdam, The Netherlands, 17 March 2025 – iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, […]